CORRESP Filing
Cyclerion Therapeutics, Inc.
Date: May 13, 2025 · CIK: 0001755237 · Accession: 0001193125-25-118816
AI Filing Summary & Sentiment
File numbers found in text: 333-287006
Show Raw Text
CORRESP 1 filename1.htm CORRESP Cyclerion Therapeutics, Inc. 245 First Street, 18 th Floor Cambridge, MA 02142 May 13, 2025 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Doris Stacey Gama Re: Cyclerion Therapeutics, Inc. Registration Statement on Form S-3 (File No. 333-287006) Request for Acceleration Ladies and Gentlemen: Pursuant to Rule 461 of the General Rules and Regulations of the Securities and Exchange Commission promulgated under the Securities Act of 1933, as amended, Cyclerion Therapeutics, Inc., a Massachusetts corporation (the “ Company ”), hereby requests that the effective date for the registration statement referred to above be accelerated so that it will be declared effective at 4:00 p.m. Eastern Time on May 15, 2025, or as soon as possible thereafter. The Company hereby authorizes William Michener of Ropes & Gray LLP, counsel to the Company, to orally modify or withdraw this request for acceleration. Please contact William Michener (william.michener@ropesgray.com) / telephone: (617) 951-7247 of Ropes & Gray LLP as soon as the registration statement has been declared effective. [ Signature page follows ] Very truly yours, CYCLERION THERAPEUTICS, INC. By: /s/ Regina Graul Name: Regina Graul, Ph.D. Title: President and Chief Executive Officer [ Signature Page to Acceleration Request ]